ArticleJAMA network open2025
Mode of Patient Sexual Orientation and Gender Identity Disclosure and Receipt of Tailored Cancer Resources.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: For lesbian, gay, bisexual, transgender, queer, questioning, and other (LGBTQ+) individuals with cancer, disclosing sexual orientation and gender identity (SOGI) in a safe clinical environment can improve survivorship outcomes and satisfaction. Although SOGI disclosure can facilitate patient-centered care, little is known about whether SOGI information is being used to improve care or how use may vary by mode of SOGI disclosure. Objective: To assess whether the mode of SOGI disclosure (self-disclosed, clinic collected, not disclosed, or other) is associated with receipt of clinical resources tailored to LGBTQ+ individuals among cancer survivors. Design, Setting, and Participants: This cross-sectional study uses data from the OUT National Cancer Survey, a web-based survey of LGBTQ+ adults with a history of cancer in the US, collected from September 2020 through March 2021. The study comprised a convenience sample of 2342 LGBTQ+ cancer survivors. Main Outcome and Measures: Multivariable logistic regression was used to assess the association between SOGI disclosure mode and receipt of at least 1 clinical resource tailored to LGBTQ+ individuals related to mental health, tobacco use, alcohol use, physical activity, or survivorship care. The primary exposure was mode of SOGI disclosure. Covariates included age, cancer type, current cancer status, and region. Results: This national sample of 2342 LGBTQ+ cancer survivors (mean [SD] age, 58.4 [16.7] years; 1428 assigned male at birth [61%]) included 79 Black participants (3%), 136 Hispanic participants (6%), 2019 White participants (86%), 64 multiracial participants (3%), and 90 participants of other race or ethnicity (4%). A total of 1394 participants (60%) identified as cisgender male, and 775 (33%) as cisgender female, and the most common sexual orientation was gay (1272 [54%]). Participants reported many cancer types, with genitourinary cancers being most common (523 [22%]). Most respondents (1798 [77%]) indicated that their care team knew their LGBTQ+ identity, with disclosure most often via self-disclosure (804 [34%]) or clinic collection (944 [42%]). Only 174 (7%) received an LGBTQ+ survivorship care plan, and 892 (38%) received at least 1 resource tailored to LGBTQ+ individuals. Compared with those with clinic-collected SOGI disclosure, those who did not disclose SOGI information (odds ratio [OR], 0.58 [95% CI, 0.44-0.78]) or who self-disclosed SOGI information (OR, 0.84 [95% CI, 0.69-1.02]) had lower odds of receiving any tailored resources. Conclusions and Relevance: In this cross-sectional study of SOGI disclosure and use, few LGBTQ+ cancer survivors received tailored clinical resources despite high rates of SOGI disclosure. Clinical use of SOGI information remained limited, especially when it was not collected systematically. Efforts should prioritize both safe SOGI data collection and its integration into patient-centered care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.